Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
2021 · Nature Communications · 144 citations
https://doi.org/10.1038/s41467-021-22177-1
P
Prasanna Jagannathan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
258
Papers
7.6K
Citations
44
h-index
115
i10-index
Prasanna Jagannathan is an academic researcher from Palo Alto University. The author has contributed to research in topics: Malaria Research and Control & Mosquito-borne diseases and control & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 44, co-authored 220 publications.
ORCID: 0000-0001-6305-758XPapers by this author
worksRelationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes
2017 · Malaria Journal · 72 citations
https://doi.org/10.1186/s12936-017-2040-4
Sex Differences in Long COVID
2025 · JAMA Network Open · 69 citations
https://doi.org/10.1001/jamanetworkopen.2024.55430
Maternal Anti-Dengue IgG Fucosylation Predicts Susceptibility to Dengue Disease in Infants
2020 · Cell Reports · 64 citations
https://doi.org/10.1016/j.celrep.2020.107642
Characterizing microscopic and submicroscopic malaria parasitaemia at three sites with varied transmission intensity in Uganda
2016 · Malaria Journal · 57 citations
https://doi.org/10.1186/s12936-016-1519-8
2024 Update of the RECOVER-Adult Long COVID Research Index
2024 · JAMA · 52 citations
https://doi.org/10.1001/jama.2024.24184
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat